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Identification and Analysis of the Core
Biosynthetic Machinery of Tubulysin, a Potent
Cytotoxin with Potential Anticancer Activity
vestigation in a variety of laboratories [4–6]. Given the
fact that myxobacteria offer an alternative and prodi-
gous source of novel bioactive compounds [7, 8], we
initiated a program aimed at the better understanding of
natural product biosynthesis and its regulation in these
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2 Pharmaceutical Biotechnology microorganisms [9–12]. Myxobacteria produce five dif-
ferent groups of compounds which have been shownSaarland University
P.O. Box 151150 to interact with the cytoskeleton of higher cells: chon-
dramides [13, 14] and rhizopodins [15] act on actin fi-66041 Saarbru¨cken
Germany bers, while epothilones [16, 17], disorazols [18], and
tubulysins (Figure 1, [19, 20]) interact with the microtu-
bule network. Whereas epothilones stabilize filament
formation, tubulysins induce their disruption (also seeSummary
Figure 2). Epothilones are currently in phase III clinical
trials as anticancer agents, while disorazol and the tubu-Myxobacteria are well known for their biosynthetic
lysins are in preclinical development. Interestingly, allpotential, especially for the production of cytotoxic
of the mentioned secondary metabolites are presumablycompounds with potential anticancer activities. The
made by polyketide synthase (PKS)/nonribosomal pep-tubulysins are currently in preclinical development.
tide synthetase (NRPS) hybrid systems, because theyThey are produced in very low quantities, and genetic
contain amino acids and typical polyketide fragments.manipulation of producing strains has never been ac-
Genetic tools to study most of the myxobacterial gen-complished. We report the development of a mariner-
era are poorly established or completely unavailable.based transposon mutagenesis system for Angiococ-
Nevertheless, the epothilone biosynthetic gene clustercus disciformis An d48. Extracts from a library of 1200
has been identified from Sorangium cellulosum [21, 22]mutants were analyzed for the presence of tubulysin
and used to heterologously produce epothilones inby a microscopic cell nucleus fragmentation bioassay.
Myxococcus xanthus [23]. However, nothing is knownThe transposition sites of four tubulysin-negative mu-
about the genetics of natural product biosynthesis intants were identified by vector recovery, which led to
the tubulysin producer.the identification and the sequencing of the corre-
This study reports the development of genetic toolssponding core biosynthetic gene locus. Sequence
for the tubulysin producer Angiococcus disciformis Ananalysis of more than 80,000 bp reveals an unusual
d48, the identification of the tubulysin biosynthetic genemultimodular hybrid polyketide synthase/peptide syn-
cluster by mariner-based transposon mutagenesis, andthetase assembly line with a variety of unprecedented
a molecular analysis of the tubulysin megasynthetase.features.
Introduction Results
Natural products interacting with the cytoskeleton of Identification of the Tubulysin Biosynthetic Gene
the cells of higher organisms are commonly used as Cluster by mariner-Based Mutagenesis
lead structures for the development of anticancer agents Because no genetic system was available for A. disci-
(e.g., taxol, dolastatin, epothilone). They are mainly derived formis An d48, growth and plating conditions for the
from plant or bacterial secondary metabolism and are strain were established and it was analyzed for its sus-
usually available in minute quantities only [1]. In order ceptibility to antibiotics [28]. As myxobacteria have been
to provide the amount needed for preclinical and clinical shown to contain a wide variety of secondary metabolic
development, research aimed at improving the supply gene clusters of the PKS/NRPS type [7, 29], it did not
of the compound is triggered once a natural product seem reasonable to screen a gene library of the strain
with promising activity is found. One possibility is chemi- for such hybrid gene clusters by using a hybridization
cal total synthesis, which is often hampered by complex approach. Instead, a transposon mutagenesis approach
stereochemistry and low overall yield [2]. Alternatively, was applied to identify the tubulysin biosynthetic gene
natural and heterologous production hosts are geneti- cluster. The theoretical size of the tubulysin biosynthetic
cally altered to increase productivity [3]. As a prerequi- gene cluster was estimated as approximately 40 kbp,
site, genetic systems must be available and the molecu- because seven biosynthetic PKS and NRPS modules
lar basis of the compound’s biosynthesis needs to be and some downstream processing genes were ex-
understood. In bacteria, most knowledge has been pected (see below). If one assumes the genome size of
gained from studies with actinomycetes and bacilli, in A. disciformis An d48 to be 10 Mbp (similar to M. xanthus
which the biosynthesis of polyketides (PKs) and nonri- and S. cellulosum [7]), a randomly inserting transposon
bosomally made peptides (NRPs) is currently under in- should hit the corresponding gene cluster in 1 out of
250 mutants. Rubin et al. [27] developed a mariner-
based transposon for mycobacteria, which can be effi-*Correspondence: rom@mx.uni-saarland.de
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fractionated. Each extract was used for another cnf
assay, because myxothiazol that is produced in parallel
can mask the activity of tubulysin. Each mutant was
shown again to be tubulysin negative. In addition,
HPLC-MS analysis of the extracts from the 50 ml cul-
tures revealed the presence of tubulysin in the wild-type,
whereas all of the mutants were shown to be tubulysin
negative (data not shown). These mutants still produce
myxothiazol.
In order to identify the transposition site in each mu-
tant, a “transposon recovery” strategy was used. Chro-
mosomal DNA was prepared and digested with restric-
tion enzymes that do not cut within the transposable
Figure 1. Structure of Tubulysins element. Religation and transformation into E. coli
DH5/pir leads to kanamycin-resistant cells which har-
bor a plasmid that consists of the transposable elementciently used to generate insertion mutants. Plasmid
(with the kanamycin resistance gene and the origin ofpMycoMar encodes the minitransposon magellan4
replication oriR6K) and chromosomal A. disciformis Anwhich contains the Tn5 kanamycin resistance gene and
d48 DNA that originally flanks the transposition site,the oriR6K, which are flanked by Himar1 inverted re-
whose sequence revealed that genes encoding PKS andpeats. In addition, pMycoMar encodes the Himar1 trans-
NRPS with high similarities to ones from other secondaryposase under the transcriptional control of the T6 pro-
metabolite gene clusters were hit. The insertion positionmotor. Himar1 transposition is characterized by a TA
of the transposons within the biosynthetic gene clusterdinucleotide recognition sequence which enables ran-
is shown in Figure 3. Restriction analysis and Southerndom integration into the target DNA. As A. disciformis
blot analysis indicated the size of each plasmid recov-An d48 turned out to be kanamycin sensitive and there
ered. After generation of a cosmid gene library of A. dis-is no evidence so far for any plasmid replicating in any
ciformis An d48, the biosynthetic gene cluster shownmyxobacterium, we directly used pMycoMar for A. disci-
in Figure 3 was cloned and sequenced from severalformis An d48 electroporation, which after optimization
overlapping plasmids and cosmids using hybridizationof the protocol (data not shown) led to a reasonably
and PCR-based strategies. The average GC contentefficient in vivo transposition protocol.
of the sequenced segment, spanning approximately 83A mutant library consisting of approximately 1200 mu-
kbp is 68.5%.tants was generated and screened using the highly sen-
sitive cell nucleus fragmentation assay (cnf) described
under Experimental Procedures, because the produc- Organization of the Tubulysin Biosynthetic
Gene Clustertion level of tubulysin does not allow detection of the
compound by simple TLC- or HPLC-based screening Sequence motifs typical for PKS domains [30, 31] and
NRPS domains [32, 33] were detected in TubA-F (Tablemethods (production is less than 1 mg/l [19]). Using the
bioassay, a concentration of approximately 50 ng/ml 1 and Figure 3; also see Figure 3 for the abbreviations
used). The acyl carrier protein (ACP) domains and thecan be detected (B. Frank, F.S., and R.M., unpublished
data). After extraction, four mutants did show a tubu- peptidyl carrier protein (PCP) domains of TubB-F con-
tain the Prosite consensus signature of the putativelysin-negative phenotype in the microtiter plate based
cnf assay. These mutants were independently grown binding site for the 4-phosphopantetheine (Ppant) co-
factor (Prosite signature numbers PS00012, R2082, andin 50 ml cultures, extracted, and the resulting extracts
Figure 2. Activity of Tubulysin against Eu-
karyotic Cancer Cells and Screen for Tubu-
lysin-Negative Mutants
(A) Influence of tubulysin A (50 ng/ml) on the
microtubule cytoskeleton of Ptk2 potoroo cells.
The cells were fixed and immunostained for
tubulin. In the upper picture microtubules of
control cells are shown (green, microtubule
network; blue, cell nuclei), the lower picture
was taken after incubation with tubulysin A
for 24 hr. Only a diffuse tubulin fluorescence
is left. Initial cell nucleus degradation can be
observed.
(B) Screen for tubulysin knockout mutants of
A. disciformis An d48 by cnf in a bioassay.
Tubulysin causes a characteristic cell nucleus
fragmentation, which can be observed in ex-
tracts from producing cells (shown in white).
Nonproducers do not induce cnf (shown in
red).
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Figure 3. Model for Tubulysin Biosynthesis
In the upper section the genetic organization of the tubulysin biosynthesis gene cluster is shown. Inserts of plasmids and cosmids generated
in this work are indicated by solid lines. The localization and transcriptional orientation of the genes is indicated by arrows which are not
drawn to scale. Underneath, a restriction map of gene locus is presented. In the lower part, a hypothetical scheme of tubulysin biosynthesis
is shown according to the domain organization of TubB-F and TubZ. Further acylation and oxidation in the presumed pretubulysin released
from TubF would result in tubulysin formation. The affected part of the molecule is shown in gray. R1 and R2 are labeled according to Figure 1.
L2104). The codon bias of the genes reported is in accor- located 10 bp behind its putative RBS GAGGA. The
domain organization of TubB-F is shown in Figure 3dance with other genes from myxobacteria [34].
The NRPS gene tubB most likely starts with an ATG and Table 1. Table 2 displays a comparison of the core
regions of the tub adenylation (A) domains, which arewhich is located 11 bp downstream of a putative ribo-
some binding site (RBS) GGTG. tubB appears to be known to be important for substrate specificity [35, 36].
Except for the TubE A-domain, the comparison revealspart of an operon with tubC-F. tubC represents another
NRPS with a putative RBS (AGGA) 8 bp upstream from good correlation with the “nonribosomal code” (see Dis-
cussion). The genes tubB-E appear to be translationallythe start codon TTG. The following gene encodes a
hybrid PKS/NRPS protein (TubD) which belongs to the coupled. The methyl transferase (MT) domains of TubB,
TubC, and TubF show the conserved S-adenosyl-methi-covalently connected PKS and NRPS modules on one
open reading frame, most of which are derived from onine binding motifs [37].
Two deviations to standard NRPS domains [33] havemyxobacteria (e.g., the MtaD or MelD proteins [11, 12]).
tubD starts with ATG and a RBS (GGGA) is located 7 bp been found in all tubulysin modules; the core motifs A2
of the A domains and the core regions of the PCP do-upstream. tubE encodes another NRPS module (a puta-
tive RBS AAGG is located 8 bp upstream of the ATG mains lack one amino acid (see Figure 4).
Upstream of tubB another putative operon, transcrip-start codon) and is followed by tubF harboring one PKS
module with a complete set of reductive loop domains tionally directed in the opposite direction can be found.
Whereas ORF1 encodes a putative ATP-dependentin addition to the methyltransferase domain and the
thioesterase domain. To our knowledge, with a MW of anion transporter and ORF2 encodes a conserved hypo-
thetical protein (Table 1), tubZ encodes a protein with309 kDa, TubF represents the largest bacterial type I
PKS module known. tubF starts with an ATG which is similarity to lysine cyclodeaminases (see Table 1). Fur-
Chemistry & Biology
1074
Table 1. Proteins Encoded in the Sequenced Region Including the Core Tubulysin Biosynthetic Gene Cluster and Their Putative Function
NRPS and PKS Part of the Gene Cluster
Proposed Function
Protein (Gene) Size (Da/bp) (Protein Domains with Their Position in the Sequence)
TubB (tubB) 170.704/4.626 NRPS domains: C (76–416), A (555–1432), N-MT (950–1403), PCP (1433–
1516)
TubC (tubC) 289.141/7.878 NRPS domains: C (77–418), A (561–1024), PCP (1025–1106), C (1137–
1477), A (1613–2496), N-MT (2004–2468), PCP (2497–2575)
TubD (tubD) 383.778/10.548 PKS domains: KS (1–437), AT (538–858), S (861–1151), KR (1155–1433),
DH (1452–1648), ER (1686–1990), ACP (2050–2150)
NRPS domains: HC (2151–2620), A (2664–3134), PCP (3135–3211), Ox
(3218–3516)
TubE (tubE) 130.337/3.546 NRPS domains: C (47–388), A (536–1049), PCP (1050–1139)
TubF (tubF) 309.369/8.514 PKS domains: KS (9–406), AT (537–858), KR (953–1260), C-MT (1295–
1653), DH (1714–1909), ER (2049–2342), ACP (2420–2501), TE (2553–
2828)
ORFs Encoded Upstream and Downstream of tubB-tubF
Accession No. of
Proposed Function of Sequence Similarity the Similar
Protein (Gene) Size (Da/bp) the Similar Protein to Source Similarity/Identity Protein
Orf16 (orf16) 122.434/3.308 valyl-tRNA synthetase Thermotoga maritima 69%/54% ZP_00080134
Orf15 (orf15) 41.337/1.254 CheY subfamily Synechocystis sp. 60%/36% NP_440346
Orf14 (orf14) 52.449/1.446 response regulator Geobacter 57%/35% ZP_00081165
metallireducens
Orf13 (orf13) 83.814/2.241 two component sensor Agrobacterium 47%/29% NP_535879
kinase/response tumefaciens
regulator hybrid
Orf12 (orf12) 58.650/1.644 60 kDa chaperonin Geobacter sulfurreducens 84%/70% NP_954380
Orf11 (orf11) 58.650/1.644 conserved hypothetical Streptomyces coelicolor 53%/33% NP_628275
protein
Orf10 (orf10) 36.441/999 nucleoside- Ralstonia metallidurans 79%/65% ZP_00026477
diphosphate-sugar
epimerases
Orf9 (orf9) 23.789/645 transcriptional regulator, Caulobacter crescentus 52%/30% NP_420005
TetR family
Orf8 (orf8) 41.614/1.137 hypothetical 119.5K Myxococcus luteus 29%/25% JQ0405
protein (uvrA region)
Orf7 (orf7) 89.255/2.346 hypothetical protein Nostoc punctiforme 46%/28% ZP_00110488
Orf6 (orf6) 43.228/1.157 serine/threonine kinase Myxococcus xanthus 47%/33% AAK64427
Pkn14
Orf5 (orf5) 68.825/1.923 protein kinase Stigmatella aurantiaca 57%/42% CAD19078
Orf4 (orf4) 33.507/921 adenine deaminase- Deinococcus radiodurans 38%/33% NP_285591
related protein
Orf3 (orf3) 20.880/543 hypothetical protein Pseudomonas syringae 46%/32% NP_790430
TubA (tubA) 43.202/1.173 similarity to C domain Nostoc punctiforme 40%/24% ZP_00109659
core motivs C1-C2
Orf2 (orf2) 25.390/660 conserved hypothetical Neurospora crassa 42%/29% CAD11370
protein
TubZ (tubZ) 39.764/1.101 lysine cyclodeaminase Streptomyces 53%/39% CAA60467
hygroscopicus
Orf1 (orf1) 46.030/1.218 anion transporting Aquifex aeolicus 65%/40% NP_213468
ATPase
Orf17 (orf17) 38.371/1.056 patatin-like protein Anabaena sp. 90 39%/23% CAC01602
Orf18 (orf18) 38.371/1.056 patatin-like protein Anabaena sp. 90 40%/24% CAC01602
Orf19 (orf19) 20.040/555 hypothetical protein Streptomyces avermitilis 35%/29% NP_823780
Orf20 (orf20) 43.282/1.158 hypothetical protein Microbulbifer degradans 62%/41% ZP_00065421
TubG (tubG) 28.039/759 N-hydroxyarylamine Streptomyces avermitilis 53%/47% NP_826733
O-acetyltransferase
Orf21 (orf21) 33.859/927 hypothetical protein Xanthomonas axonopodis 39%/28% NP_641500
Orf22 (orf22 32.668/882 hypothetical protein Rhizobium etli 49%/37% NP_659913
Orf23 (orf23) 49.133/12.63 similar to penicillin Gloeobacter violaceus 67%/49% NP_926044
binding protein
Orf24 (orf24) 37.621/1.077 NosF Nostoc sp. 44%/31% AAF17284
ther upstream, TubA is encoded, which represents a upstream revealed the presence of several putative reg-
ulators and two component systems, which are brieflyprotein with similarity to fragments of C domains from
NRPSs. Sequence analysis of an additional 31.2 kbp described in Table 1 (see EMBL entry). Downstream of
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Table 2. Substrate Specificity Pocket of tub A-Domains
Position of the amino acid within 235 236 239 278 299 301 322 330
the A-domain
Consensus pipecolic acid D Y Q Y C/L G H L
A-domain TubB D I Q Y I A Q V
Consensus isoleucine D G A F F L F Y G V I V T
A1-domain TubC D A F F L G V T
Consensus valine D A V F F Y W W F M I F L A G A G T V
A2-domain TubC D A F W L G G T
Consensus cysteine D L H Y F E N S M L D S I V M L G I
A-domain TubD D L Y N M S L I
Consensus tyrosine D G A T L I G T A G E V
Consensus phenylalanine D A L P F W I T G M V I G A G A T V I
A-domain TubE A L Y W L A S F
The numbering of the amino acids corresponds to the GrsA gramicidin synthetase. The GrsA phenylalanine substrate pocket has been
crystallized [43], which led to the establishment of the nonribosomal code [35, 36].
tubF, 13 kbp of DNA were sequenced and analyzed. gene cluster. Based on the in silico analysis of the genes
involved, a hypothetical biosynthetic route to tubulysinWithin this region, genes encoding hypothetical ORFs
were detected. In addition, a protein with similarity to could be established as described below.
acyltransferases was found (Figure 3 and Table 1).
Proposed Biosynthetic Pathway to Tubulysin
Discussion in A. disciformis An d48
Tubulysin biosynthesis most likely starts with the bio-
After the description of the epothilone biosynthetic gene synthesis of pipecolic acid from lysine via the action of
cluster [21, 22], this is only the second report of a mega- the putative lysine cyclodeaminase TubZ. This proposal
synthetase involved in the biosynthesis of a tubulin- is in accordance with the description of RapL, a protein
interacting compound from a myxobacterium. As tubu- highly similar to TubZ, which has been found in the
lysin has a different mode of action from epothilone, it is rapamycin biosynthetic gene locus. RapL is proposed
expected that the modification of tubulysin biosynthesis to be a lysine cyclodeaminase based on mechanistic
will similarly trigger research toward the generation of and sequence comparisons with ornithine cyclodeami-
improved tubulysin analogs in the future. nase [38]. TubB indeed contains an A-domain with a
Analysis of 1200 mutants of A. disciformis An d48 and substrate binding pocket typical for pipecolic acid (see
localization of the insertion positions in the genome of Table 2). Differing from rapamycin biosynthesis, the pi-
tubulysin nonproducers, all of which mapped to the pecolic acid moiety in tubulysin is N-methylated, which
same gene locus, led to the identification of the tubulysin is consistent with the finding that a MT domain is located
within the A-domain of TubB. The insertion of domains
within A-domains is unusual but not unprecedented; the
MT domains of TubB and TubC are located between
A-domain core regions A8 and A9, similar to microcystin
biosynthetic protein MycA [39]. Interestingly, insertion
of oxidation (Ox) domains at the same position has been
reported for the myxothiazol biosynthetic proteins MtaD
and MtaG (between core motifs A8 and A9 and between
A4 and A5, respectively) [11]. In contrast, most of the known
NRPS MT domains are located between the A- and PCP
domains [33]. The biosynthetic role of the C domain at
the N terminus of TubB is not clear, but it might have
some function in the acylation of the product of the PKS/
NRPS system (see below). Further, we propose that
TubC extends the methylated pipecolic acid bound
to the TubB-PCP with isoleucine and valine (which
corresponds well with the nonribosomal code of the
A-domains involved; see Table 2), the latter of which
will be N-methylated by the TubC MT domain that is
similar to the one in TubB.
At this point, the biosynthetic intermediate switchesFigure 4. Tubulysin Core Motifs A2 from A-Domains and Core Motifs
to TubD, a hybrid of PKS and NRPS. The first moduleof PCP Domains Differ from Standard NRPS Domains
of the protein represents a PKS containing a completeConsensus core domain motifs are shown according to Konz and
reductive loop that is used for the extension with a malo-Marahiel [33]. Amino acids “missing” in the tubulysin domains are
indicated in gray. nate moiety, which perfectly matches the final natural
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product. Surprisingly, the order of the domains within the acylation reactions. The latter could be catalyzed
by the N-terminal C domain of TubB in analogy to lipo-the reductive loop is different from that of other known
PKS systems. The KR domain is found C-terminal from peptide biosynthesis, where N-terminal C domains are
believed to couple an CoA-activated lipid to the peptidethe AT domain and followed by DH and ER domains,
the latter of which is attached to the ACP domain. In core [41]. Nevertheless, the C domain of TubB does
not cluster with such C domains in phylogenetic treecontrast, typical reductive loops follow the order KS-
AT-DH-ER-KR-ACP. The same atypical organization is analysis (data not shown). Alternatively, TubA could be
involved in the acylations, because it shows similarityalso found in TubF (with the exception that a MT domain
is inserted between the KR and DH domains). Such to fragments of NRPS C-domains (only core motifs C1
and C2 can be identified). On the other hand, it hasan unusual domain organization should influence the
corresponding three-dimensional structure of PKS and been shown that core motif C3 is necessary for acyl
transferase activity [42]. Thus, tubG located 7 kb down-especially PKS/NRPS hybrid systems and thus shows
the high degree of structural flexibility of these megasyn- stream of tubF, seemed to be the most likely candidate
gene for the acylation reaction(s). After establishing athetases, which could possibly suggest new experimen-
tal approaches to generate engineered enzymes and to preliminary and so far inefficient system for gene inacti-
vation by homologous recombination in A. disciformisbetter understand the currently obscure topology of the
multidomain proteins during multistep catalysis. An d48, the gene was inactivated with no effect on tubu-
lysin biosynthesis (A.S. and R.M., unpublished data).The NRPS module of TubD contains a heterocycliza-
tion domain, a cysteine-specific A-domain (see Table Therefore, it is not clear at this stage how the oxidation
and acylation reactions are performed. Further experi-2), a PCP and an Ox domain (which is located behind
the PCP). The Ox domain of EpoP was shown to oxidize ments aimed at the identification of the post-PKS pro-
cessing genes in A. disciformis An d48 are in progress.the intermediate thiazoline ring after heterocyclization
of cysteine during epothilone biosynthesis [40]. Next, The description of the tubulysin core biosynthetic
genes which are most likely located between tubA andTubE extends the growing chain with phenylalanine or
tyrosine, finally resulting in the production of tubulysin orf17 (Figure 3) sets the stage for a detailed genetic and
biochemical analysis of the biosynthesis of the com-D or A, respectively. The A-domain of this protein shows
no significant similarity to any amino acid “specificity pound. Studies aimed at increasing the tubulysin yield,
as well as the heterologous expression of the core bio-pocket,” and we hypothesize that it is capable of loading
either amino acid. We have identified a number of other synthetic genes are in progress.
atypical A-domains from myxobacteria which signifi-
cantly differ from the “nonribosomal code.” Sequence
Significancecomparisons show that such differences exist for cyano-
bacterial NRPS domains as well (A.S., Silke Wenzel, and
Microorganisms are used as production hosts for anR.M., unpublished data, cp. [39]). Further examples of
immense variety of natural products with various bio-deviations from well-defined core regions of NRPSs [33]
logical activities. Myxobacteria are gaining attentioncan be found in the tubulysin megasynthetase; both the
due to their biosynthetic potential, especially for theA-domain core A2 and the PCP domain core lack one
production of cytotoxic compounds with potential an-conserved amino acid (see Figure 4). The effect of these
ticancer activities. The epothilones and the tubulysinsamino acid exchanges and deletions remains to be eluci-
are examples in clinical and preclinical development,dated.
and the potential of tubulysins is demonstrated byTubF, the last protein in the tubulysin assembly line,
the extremely low concentration needed to inhibit thecontains eight active domains and thus represents the
growth of mammalian cell lines by 50% (IC50 value inlargest known bacterial type I PKS module. Between
the picomolar range). Tubulysins are produced in verythe KR and DH domains a MT is found, which most likely
low quantities, and genetic manipulation of producingmethylates the -keto intermediate in the  position,
strains has not been reported. This fact prompted uswhich eventually results in the methyl group in position
to develop a mariner-based transposon mutagenesis2 of tubulysin. All methyl groups correlated to the de-
system for the tubulysin producer Angiococcus disci-scribed MT domains have been shown by feeding exper-
formis An d48 and identifiy the core biosynthetic geneiments to be derived from 13C-labeled methionine [20].
cluster for tubulysin. Extracts from 1200 mutants wereAction of the KR, DH, and ER domains results in the
analyzed for their ability to produce the compoundsaturated and ACP-bound intermediate that is finally
by a microscopic cell nucleus fragmentation bioassayreleased by the action of TubF TE-domain as free acid.
based on sensitive mouse cells. No tubulysin activityThe assumed product released from the PKS/NRPS
was detected in extracts of four mutants. Each corre-assembly line would now have to be oxidized in posi-
sponding transposition site was identified by vectortions 39 and 11, followed by acylations of the resulting
recovery, revealing that all of the mutants group to theOH groups (see Figure 3). However, no candidate gene(s)
same gene locus. The identified core tubulysin biosyn-for these two oxidation processes could be found within
thetic gene cluster is approximately 40,000 bp in sizethe sequenced region, indicating that both reactions
and represents a multimodular hybrid polyketide syn-might be performed by enzymes encoded outside of the
thase/peptide synthetase assembly line with a varietyidentified biosynthetic region. Alternatively, oxidases
of unprecedented features. The biosynthesis of theencoded in the sequenced region which cannot be iden-
unusual N-methyl pipecolic acid starter moiety can betified as such by computer-based analysis might be
involved in the biosynthesis. The same holds true for explained, and a novel arrangement of reductive loops
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Toxicity Assayin polyketide synthases is reported. The identification
L929 mouse cells (DSMZ: ACC2) were cultivated in DME mediumof the gene cluster is relevant for potential combinato-
(Invitrogen, Groningen, The Netherlands) at 37C and harvested us-rial biosynthesis and sets the stage for the develop-
ing a cell scraper. The resulting cell suspension was diluted with
ment of engineered tubulysin derivatives. DME medium to a cell density of 50,000/ml and 120l of this suspen-
sion were aliquoted into each well of a 96-well plate. An aliquot
(10 l) of the extract from each A. disciformis An d48 mutant was
Experimental Procedures
added to the wells and the mixture was incubated for 5 days at 37C.
Subsequently, the L929 mouse cells were analyzed for tubulysin-
DNA Manipulations, Analysis, Sequencing, and PCR
induced cnf using a Zeiss Axiovert fluorescence microscope (Fig-
A. disciformis An d48 chromosomal DNA was prepared as described
ure 2) [19].
[24]. Southern blot analysis of genomic DNA was performed using
For the verification of the result, mutants whose extracts failed
the standard protocol for homologous probes of the DIG DNA label-
to disrupt cell nuclei in the cnf assay were grown for 9 days in
ing and detection kit (Roche Diagnostics, Mannheim, Germany).
50 ml M7 medium containing 1 ml adsorber-resin Amberlite XAD-
Sequencing of the transposon plasmid pMutT794 and the cosmid
16 (Rohm & Haas, Frankfurt/Main). Cells were harvested, extracted
F11 was performed by a shotgun approach as described previously
as described [19], and their extracts were used for a second cnf
[11]. Polymerase chain reaction (PCR) was carried out using Pfu
assay. In addition, extracts were fractionated by HPLC [20 l of
DNA-Polymerase (Stratagene) according to the manufacturer’s pro-
each sample was loaded onto the HPLC-column (Nucleosil 120-3
tocol. DMSO was added to the reaction mixture to a final concen-
C18, 2  125 mm, Macherey-Nagel, Du¨ren) and chromotographedtration of 5%. Conditions for amplification with the Eppendorf
at a flow rate of 0.5 ml/min. Fractions were collected over 30 s,
Mastercycler gradient (Eppendorf, Germany) were as follows: dena-
corresponding to a total volume of 250 l per fraction and each
turation for 30 s at 95C, annealing for 30 s at 60C and extension
fraction was subjected to the cnf assay. This approach effectively
for 45 s at 72C; 30 cycles and a final extension at 72C for 10 min.
separates tubulysin from myxothiazol, another secondary metabo-
Primers used for the amplification of an internal fragment of tubA
lite produced by A. disciformis An d48 (F.S., unpublished data).
(given in the 5 to the 3 direction): TubAup 5-CAG CAT GTC GAG Myxothiazol can mask the tubulysin activity in lower dilutions (F.S.,
GCA GAG C-3; TubAdown 5-TCC CGA GCA TCC AAC GCA GAG-3; unpublished data) as it inhibits the electron transport chain and
internal fragment of orf1: Orf1up 5-CCC TTC GGC AGC CCC AAC leads to cell death leaving the cell nuclei intact while tubulysin
AT-3, Orf1down 5-GCC CGG CAA GAC AGA GC-3; internal fragment causes apoptosis and thus cell nucleus fragmentation. Thus, the
of tubZ: TubZup 5-GGA GGT GGC CGT GCA GAG GAT GTC-3, loss of tubulysin activity is evident by the presence of nonfrag-
TubZdown 5-CTG CAC GCG CTG ATG GAT GAG GTC-3; internal mented nuclei. In parallel, the integrity of the L929 mouse cell nuclei
fragment of orf2: Orf2up 5-TCC AGG TAG GCA GAT TGA GAC-3, used in the cnf assay were analyzed by staining with 4-6-diamino-
Orf2down 5-CAG CGG CAG TGG AGT GAA G-3; internal fragment 2-phenylindodol (DAPI) (Vollenweider, 1992). Both, the toxicity and
of tubC: ASTls 2A 5-GCT CCC GGG CCA CGT GGT TGA AGA-3,
the staining method clearly identified four tubulysin mutants:
ASTls 2B 5-CCG CGG GCC GTG GCA GTG GTG TA-3; internal
MutT176, MutT781, MutT794, and MutT929.
fragment of tubD: ASTls 1A 5-CAC CCG GAC CTG CCT GGA TTC-3,
ASTls 1B 5-TGC TCG GCT GGC GCT ACT CAC-3; fragment behind
Identification of the mariner-TranspositiontubF: Tlsup 5-TGG CAG CCA GCC CGA GC-3; SeqTE 5-GAC GCT
Site by Vector RecoveryGCT GCG GCC ACC TCA CG-3.
Chromosomal DNA (5 g) prepared from each A. disciformis An d48All other DNA manipulations were performed according to stan-
mutant grown in tryptone were digested using NotI and BamHI,dard protocols [25]. Amino acid and DNA alignments were done
phenol/chloroform purified, and ligated overnight at 16C. The liga-using the programs of the Lasergene software package (DNAstar
tion mixture (1–3 l) was electroporated into E. coli DH5-pir cells.Inc.) and ClustalW [26].
Plasmids extracted from resulting kanamycin-resistant colonies
were used for sequencing with primers K-388: 5-TGG GAA TCA
TTT GAA GGT TGG-3 and K-390 5-GGG TAT CGC TCT TGA AGGGeneration of a Mutant Library of A. disciformis
GAA C-3.An d48 by Transposon Mutagenesis
A. disciformis An d48 was cultivated at 30C in 50 ml tryptone me-
dium (10 g tryptone, 2 g MgSO4, 0.1% vitamin B12 [10 ng/ml], 0.2% Cloning and Sequencing of the Tubulysin
Biosynthetic Gene Clusterglucose per liter medium, pH adjusted to 7.2) to a cell density of
2  108 cells/ml. Cells were harvested by centrifugation at 20C (20 Plasmid pMutT794/NotI harbors 52,985 bp of chromosomal DNA
from A. disciformis An d48 (see Figure 3). Together with the trans-min, 4000 rpm) and resuspended in an equal amount of washing
buffer (5 mM HEPES, 0.5 mM CaCl2, pH adjusted to 7.2 using NaOH). posable element, 55,184 bp were sequenced. To clone the rest of
the tubulysin biosynthetic gene cluster, a cosmid library of A. dis-After a second washing step in 25 ml buffer, cells were resuspended
to give a final cell count of 1  109 cells in 40 l. Transposon ciformis An d48 was prepared as described [11]. In colony hybridiza-
tion experiments, approximately 1920 cosmid-harboring single col-pMycoMar (1–3 g; [27]) and 40 l cell suspension were mixed and
transferred into an ice-cold electroporation cuvette (0.1 cm). The onies were used according to the manufacture’s protocol (Roche
Diagnostics, Mannheim) under stringent conditions. Screeningelectroporation conditions were: 200 	, 25 mF, and 0.85 kV/cm.
Tryptone medium (1 ml) was added to the cells and the suspension probes were derived from tubC and tubD (oligonucleotides ASTls
2 A/B were used to generate the probe derived from tubC and primerwas transferred into an Erlenmeyer flask with 50 ml tryptone me-
dium. After incubation for 6 hr at 30C, cells were harvested (20 pair ASTls 1A/B was used to generate the probe derived from tubD).
Cosmids F4, F5, F7, F11, F13, and F16 were identified and furthermin, 4000 rpm, 20C) and resuspended in 1 ml tryptone medium. A
dilution series of 1  108 to 1  104 cells was plated with 3 ml analyzed by PCR and restriction analyses. Additionally, these six
cosmids were end sequenced and physically mapped (data nottryptone soft agar onto kanamycin selection tryptone medium (50
g/ml). Mutant-colonies became visible after incubation at 30C for shown). The size of the overlap with known tub sequence was de-
fined (see Figure 3).5–8 days.
A total of 1200 mutants were transferred into 96-well plates filled Cosmid F11 was sequenced and harbors tubD, tubE, and tubF.
Using PCR and Southern analysis, (primers Tlsup/SeqTE were usedwith 200 l M7 medium per well (5 g probion [single-cell protein;
Ho¨chst AG], 1 g CaCl2, 1 g MgSO4, 1 g yeast extract, 5 g soluble to generate the probes) another cosmid (F7) harboring DNA located
downstream of the tubulysin gene cluster was isolated. A NsiI/EcoRIstarch, 10 g HEPES, 0.1% vitamin B12 [10 ng/ml] per liter medium,
adjusted to pH 7.4) and incubated at 32C. After cultivation for 10 fragment from F7 approximately 12 kbp in size was isolated and
cloned into pUC18 (predigested with PstI/EcoRI) resulting in plasmiddays, 150 l of each suspension was taken to dryness at 37C (N2
gas). Cell pellets were resuspended in 100 l methanol, 10 l of pASM12. This plasmid was subjected to in vitro transposition using
the GPS-1 Genome Priming System (New England Biolabs,which were used for a cell nucleus fragmentation (cnf) assay to
detect the presence of tubulysin in each extract. Schwalbach) according to the manufacturer’s protocol. Plasmid
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DNA was extracted from 192 kanamycin-resistant colonies and se- acting on the actin cytoskeleton. J. Natl. Cancer Inst. 90, 1559–
1563.quenced using primers N and S (N: 5-ACT TTA TTG TCA TAG TTT
AGA TCT ATT TTG-3; S: 5-ATA ATC CTT AAA AAC TCC ATT TCC 15. Sasse, F., Steinmetz, H., Hofle, G., and Reichenbach, H. (1993).
Rhizopodin, a new compound from Myxococcus stipitatusACC CCT-3).
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